I didn't hear the SGP call yet but did Fred say he wants to do a deal in general and posters on investor village think an HCV one or did Fred say in that area?
Why would they be interested in Vertex is their (SGP's) protease inhibitor thought to be that much worse then Vertex's? I would think with Roche having a Polymerase Inhibitor that would be more the area of focus.
Market Data 
Markets 
AI
